LCTX
Price
$0.41
Change
-$0.00 (-0.00%)
Updated
Apr 10 closing price
Capitalization
94.68M
27 days until earnings call
VTGN
Price
$2.05
Change
-$0.01 (-0.49%)
Updated
Apr 10 closing price
Capitalization
58.3M
Ad is loading...

LCTX vs VTGN

Header iconLCTX vs VTGN Comparison
Open Charts LCTX vs VTGNBanner chart's image
Lineage Cell Therapeutics
Price$0.41
Change-$0.00 (-0.00%)
Volume$755.13K
Capitalization94.68M
VistaGen Therapeutics
Price$2.05
Change-$0.01 (-0.49%)
Volume$139.09K
Capitalization58.3M
LCTX vs VTGN Comparison Chart
Loading...
LCTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LCTX vs. VTGN commentary
Apr 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LCTX is a Hold and VTGN is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 11, 2025
Stock price -- (LCTX: $0.41 vs. VTGN: $2.05)
Brand notoriety: LCTX and VTGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LCTX: 52% vs. VTGN: 85%
Market capitalization -- LCTX: $94.68M vs. VTGN: $58.3M
LCTX [@Biotechnology] is valued at $94.68M. VTGN’s [@Biotechnology] market capitalization is $58.3M. The market cap for tickers in the [@Biotechnology] industry ranges from $263.69B to $0. The average market capitalization across the [@Biotechnology] industry is $1.94B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LCTX’s FA Score shows that 0 FA rating(s) are green whileVTGN’s FA Score has 0 green FA rating(s).

  • LCTX’s FA Score: 0 green, 5 red.
  • VTGN’s FA Score: 0 green, 5 red.
According to our system of comparison, LCTX is a better buy in the long-term than VTGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LCTX’s TA Score shows that 4 TA indicator(s) are bullish while VTGN’s TA Score has 4 bullish TA indicator(s).

  • LCTX’s TA Score: 4 bullish, 4 bearish.
  • VTGN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both LCTX and VTGN are a good buy in the short-term.

Price Growth

LCTX (@Biotechnology) experienced а -1.75% price change this week, while VTGN (@Biotechnology) price change was -10.09% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.43%. For the same industry, the average monthly price growth was -15.00%, and the average quarterly price growth was -16.98%.

Reported Earning Dates

LCTX is expected to report earnings on Aug 07, 2025.

VTGN is expected to report earnings on Aug 10, 2023.

Industries' Descriptions

@Biotechnology (+2.43% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LCTX($94.7M) has a higher market cap than VTGN($58.3M). LCTX YTD gains are higher at: -18.408 vs. VTGN (-30.508). LCTX has higher annual earnings (EBITDA): -20.87M vs. VTGN (-52.22M). VTGN has more cash in the bank: 88.6M vs. LCTX (47.8M). VTGN has less debt than LCTX: VTGN (1.71M) vs LCTX (2.51M). LCTX has higher revenues than VTGN: LCTX (9.5M) vs VTGN (698K).
LCTXVTGNLCTX / VTGN
Capitalization94.7M58.3M162%
EBITDA-20.87M-52.22M40%
Gain YTD-18.408-30.50860%
P/E RatioN/AN/A-
Revenue9.5M698K1,361%
Total Cash47.8M88.6M54%
Total Debt2.51M1.71M147%
FUNDAMENTALS RATINGS
LCTX vs VTGN: Fundamental Ratings
LCTX
VTGN
OUTLOOK RATING
1..100
6769
VALUATION
overvalued / fair valued / undervalued
1..100
38
Fair valued
45
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9394
PRICE GROWTH RATING
1..100
9190
P/E GROWTH RATING
1..100
47100
SEASONALITY SCORE
1..100
n/a12

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LCTX's Valuation (38) in the null industry is in the same range as VTGN (45) in the Biotechnology industry. This means that LCTX’s stock grew similarly to VTGN’s over the last 12 months.

LCTX's Profit vs Risk Rating (100) in the null industry is in the same range as VTGN (100) in the Biotechnology industry. This means that LCTX’s stock grew similarly to VTGN’s over the last 12 months.

LCTX's SMR Rating (93) in the null industry is in the same range as VTGN (94) in the Biotechnology industry. This means that LCTX’s stock grew similarly to VTGN’s over the last 12 months.

VTGN's Price Growth Rating (90) in the Biotechnology industry is in the same range as LCTX (91) in the null industry. This means that VTGN’s stock grew similarly to LCTX’s over the last 12 months.

LCTX's P/E Growth Rating (47) in the null industry is somewhat better than the same rating for VTGN (100) in the Biotechnology industry. This means that LCTX’s stock grew somewhat faster than VTGN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LCTXVTGN
RSI
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 3 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 3 days ago
85%
Momentum
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 3 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 3 days ago
89%
Advances
ODDS (%)
Bullish Trend 19 days ago
77%
Bullish Trend 19 days ago
82%
Declines
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 3 days ago
86%
Aroon
ODDS (%)
Bearish Trend 1 day ago
85%
N/A
View a ticker or compare two or three
Ad is loading...
LCTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SXOOF0.04N/A
+3.83%
St Georges Eco Mng Corp.
ZURVY33.980.50
+1.50%
Zurich Insurance Group Ltd
VEOEY16.66-0.01
-0.07%
Veolia Environnement
SEOAY8.36-0.45
-5.11%
Stora Enso Oyj
AKCCF0.32-0.02
-5.88%
AKER CARBON CAPTURE ASA

VTGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTGN has been loosely correlated with ABOS. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if VTGN jumps, then ABOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTGN
1D Price
Change %
VTGN100%
-0.49%
ABOS - VTGN
45%
Loosely correlated
-3.77%
ATAI - VTGN
42%
Loosely correlated
-6.92%
KYMR - VTGN
42%
Loosely correlated
-6.47%
ZYME - VTGN
41%
Loosely correlated
-5.60%
RCKT - VTGN
40%
Loosely correlated
-8.52%
More